Loading...
NPI 1770053548 · Milford, DE · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Lab At Seascape is a clinical medical laboratory provider located in Milford, Delaware. This profile covers 83 Medicare and 28 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Lab At Seascape |
| Address | 200 W Liberty Way Ste B |
| City | Milford |
| State | DE |
| ZIP | 19963 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | December 4, 2018 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $1M |
| Medicaid | $471.9K |
LAB AT SEASCAPE presents as a clinical medical laboratory with a clear operational emphasis on mobile specimen collection and community testing: the single largest Medicare code is P9603 (travel allowance) with 324.2K claims and $324.2K revenue (35.7% of its Medicare revenue), and Medicaid billing is dominated by U0003 (SARS‑CoV‑2 PCR) with 14.4K claims and $301.4K revenue (64.7% of its Medicaid revenue). The presence of P9604 and P9615 in Medicare and high G2024/U0005 volumes in Medicaid further supports a business model that combines home‑ or facility‑based specimen collection with high-throughput infectious disease testing.
Revenue concentration is marked and payer-specific: the top 3 Medicare codes account for 54.9% of this provider's total Medicare revenue, while the top 3 Medicaid codes account for 83.5% of its total Medicaid revenue. This indicates Medicare revenue is concentrated but more distributed across codes compared with Medicaid, where a few codes—primarily COVID PCR and related collection services—dominate.
In scale the provider reports $1M in total Medicare revenue versus $471.9K in total Medicaid revenue, so Medicare represents the larger single-payer source on file. Both payers are material to the business, however, and Medicaid activity is highly concentrated in SARS‑CoV‑2 testing codes, meaning payer mix shifts or pandemic testing demand changes could swing overall revenue materially.
National competitive standing on key Medicare codes is mixed: P9603 ranks #39 of 267 (86th percentile) which places the provider above the median national peer group for travel‑allowance specimen collection but within a ‘typical, unremarkable’ volume band. At the same time several routine chemistry and hematology panels (for example 80053, 80048, 85025) are at very high national percentiles (98–99th), indicating strong throughput for standard lab testing relative to national peers.
State-level competitive positioning for Medicaid is concentrated and prominent on COVID testing: U0003 ranks #1 of 5 in-state (100th percentile) and is described as notably above typical state volume, showing the provider is a dominant in-state PCR tester for Medicaid enrollees. G2024 also appears as a primary Medicaid source (6.3K claims, $44K revenue) and is the only in-state reporter for that code here, which suggests ownership of certain specimen-collection workflows in post-acute or home health settings.
There are clear statistical outliers in the provider's profile that are operationally informative: Medicare P9615 (catheterization for collection) ranks #1 of 19 nationally and is labeled an “extreme outlier, far above typical national volume,” which signals unusually high specialized collection activity even though that code represents a smaller share ($15.2K) of Medicare revenue. Another extreme outlier is Medicare 87804 (rapid influenza immunoassay) which also appears far above typical national volume; these outliers point to specific service lines where this lab operates at much higher intensity than most peers.
Service-line mix indicates the lab combines routine clinical testing with infectious disease surveillance and mobile collection: Medicare line items such as 36415, 80053, 80048, 85025 and 83036 show substantial routine phlebotomy and panel testing volumes (e.g., 36415: 15.6K claims, $124.6K revenue), while Medicaid and Medicare U0003/U0005 and G2024 activity show heavy SARS‑CoV‑2 molecular testing and related collection services. The combination suggests a lab configured for both high-throughput assay processing and decentralized specimen collection from homebound or institutionalized patients.
The provider's NPI was enumerated on 2018-12-04 (~8 years ago), so it is an established but relatively recent entrant compared with decades-old labs; this tenure, combined with very high percentile rankings on selected codes, suggests rapid scaling in targeted service lines (mobile collection and infectious disease testing) since enrollment. Analysts should treat the provider as an operationally focused lab with concentrated dependencies on a few high-volume codes, particularly COVID PCR and home-bound specimen collection, when assessing network capacity or contracting risk.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
83 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | 324,210 | $1 | $324.2K |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 15,570 | $10 | $124.6K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 680 | $70 | $50.2K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 4,320 | $10 | $43.2K |
| 80048 | The lab analyst performs a basic metabolic pane (BMP) test in which he measures the blood level of eight chemicals including total calcium, sodium, potassium, chloride, carbon dioxide, glucose, blood… | 4,990 | $10 | $40K |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 2,130 | $20 | $34K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 4,150 | $10 | $33.2K |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 2,140 | $10 | $27.9K |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 900 | $30 | $26.2K |
| 85027 | The lab analyst performs a blood count on the red and white blood cells and platelets also known as thrombocytes. He also determines the hemoglobin, typically by spectrophotometry, and the… | 3,910 | $10 | $23.5K |
Showing 1–10 of 83
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 83 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
28 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 14,350 | $20 | $301.4K |
| G2024 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen… | 6,290 | $10 | $44K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc,… | 7,260 | $10 | $43.5K |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | 21,190 | $1 | $21.2K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 3,830 | $1 | $15.3K |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 13,290 | $1 | $13.3K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 2,870 | $1 | $5.7K |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | 410 | $10 | $4.5K |
| 80048 | The lab analyst performs a basic metabolic pane (BMP) test in which he measures the blood level of eight chemicals including total calcium, sodium, potassium, chloride, carbon dioxide, glucose, blood… | 4,010 | $1 | $4K |
| 85027 | The lab analyst performs a blood count on the red and white blood cells and platelets also known as thrombocytes. He also determines the hemoglobin, typically by spectrophotometry, and the… | 3,760 | $1 | $3.8K |
Showing 1–10 of 28
How this provider's Medicaid billing volume and revenue compare to other Delaware providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Delaware median
28 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 8 | 10 | 19,870 | $20 | $426.3K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 1 | 10 | 5,520 | $50 | $282.6K |
| 80048 | The lab analyst performs a basic metabolic pane (BMP) test in which he measures the blood level of eight chemicals including total calcium, sodium, potassium, chloride, carbon dioxide, glucose, blood… | 8 | 10 | 7,360 | $10 | $214.1K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 9 | 30 | 960 | $10 | $178.7K |
| 81001 | Urinalysis is used to detect substances or cellular material in the urine associated with different metabolic and kidney disorders. It is used to detect urinary tract infections (UTI) and other… | 9 | 10 | 5,550 | $10 | $102.9K |
| 87086 | Culture, bacterial; quantitative, colony count, urine. | 8 | 10 | 8,310 | $10 | $101.1K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc,… | 2 | 10 | 4,780 | $10 | $92.8K |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 9 | 20 | 1,390 | $10 | $89.2K |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 8 | 10 | 4,430 | $10 | $72.4K |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 8 | 40 | 1,650 | $1 | $60.7K |
Showing 1–10 of 28
Other providers in the same ZIP code as Lab At Seascape, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.